Scientists recreate blood-brain barrier on a chipScientists in Israel and the US have duplicated the blood-brain barrier in a chip using human stem cells, Share XScientists recreate blood-brain barrier on a chiphttps://pharmaphorum.com/news/scientists-recreate-blood-brain-barrier-on-a-chip/
Roche’s Gazyva shows promise in Lupus nephritis trialRoche’s Gazyva is already approved in leukaemia and lymphoma – but could it work in the autoimmune kidney Share XRoche’s Gazyva shows promise in Lupus nephritis trialhttps://pharmaphorum.com/news/roches-gazyva-shows-promise-in-lupus-nephritis-trial/
Janssen to develop Darzalex successor with GenmabJanssen has signed a licence and option deal with Denmark’s Genmab to develop a next-generation drug that it Share XJanssen to develop Darzalex successor with Genmabhttps://pharmaphorum.com/news/janssen-to-develop-darzalex-successor-with-genmab/
Novo Nordisk builds cardio claim case for oral semaglutideNovo Nordisk’s bid to disrupt the diabetes market with an oral formulation of its GLP-1 agonist semaglutide has Share XNovo Nordisk builds cardio claim case for oral semaglutidehttps://pharmaphorum.com/news/novo-nordisk-builds-cardio-claim-case-for-oral-semaglutide/
Exscientia begins China AI drug discovery tie-up with GT ApeironUK Artificial Intelligence (AI) drug discovery firm Exscientia has begun a collaboration with China’s GT Apeiron Therapeutics, focusing Share XExscientia begins China AI drug discovery tie-up with GT Apeironhttps://pharmaphorum.com/news/exscientia-begins-china-ai-drug-discovery-tie-up-with-gt-apeiron/
Merck claims a brace of head and neck cancer approvalsMerck & Co/MSD has done the double in head and neck cancer with a pair of FDA approvals Share XMerck claims a brace of head and neck cancer approvalshttps://pharmaphorum.com/news/merck-claims-a-brace-of-head-and-neck-cancer-approvals/
Many patients don’t have, or are unaware of e-health records, says reportNetherlands-based health technology firm Royal Philips has published its fourth global report exploring the impact of digital health Share XMany patients don’t have, or are unaware of e-health records, says reporthttps://pharmaphorum.com/news/many-patients-dont-have-or-unaware-of-e-health-records-says-report/
Insys throws in the towel and files for bankruptcyInsys has declared bankruptcy, hard on the heels of its agreement last week to a $225 million payment Share XInsys throws in the towel and files for bankruptcyhttps://pharmaphorum.com/news/insys-throws-in-the-towel-and-files-for-bankruptcy/
FDA approves Roche’s $90,000 lymphoma combinationThe FDA has quickly approved a new antibody treatment for an aggressive form of lymphoma from Roche – Share XFDA approves Roche’s $90,000 lymphoma combinationhttps://pharmaphorum.com/news/fda-approves-roches-90000-lymphoma-combination/
